Nobody has filed for crossing 5%. That is a fact, not missing data.
GHM planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Thoren Daniel J.
Filed 2026-08-13
$5.6M
Thoren Daniel J.
Filed 2026-07-06
$3.1M
Thoren Daniel J.
Filed 2026-06-23
$5.4M
Corporate PAC
The company's PAC: committee totals only, never individual donors (FEC).
Fund For America'S Future
Cycle 2026 · $605K spent
$632.1K
Federal Election Commission, matched by the PAC's connected organisation
Executive pay vs shareholder return · Daniel JThoren
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$2.3M
$4.8M
$876.2K
+96%
+14%
2022
$1.1M
$1.8M
$597.6K
-6%
-6%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows $5.6M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$261.1M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM GHM
FY Mar 2026
$245.3M
FY Mar 2025
$209.9M
FY Mar 2024
$185.5M
FY Mar 2023
$157.1M
FY Mar 2022
$122.8M
Jun 2026
$71.3M
Mar 2026
$67.1M
Dec 2025
$56.7M
Sep 2025
$66.0M
Jun 2025
$55.5M
Mar 2025
$59.3M
Dec 2024
$47.0M
Sep 2024
$53.6M
At each fiscal year end
Single quarter
Net margin, TTM
+4.5%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM GHM
FY Mar 2026
+5.1%
FY Mar 2025
+5.8%
FY Mar 2024
+2.5%
FY Mar 2023
+0.2%
FY Mar 2022
-7.1%
Jun 2026
+5.5%
Mar 2026
+2.9%
Dec 2025
+5.0%
Sep 2025
+4.7%
Jun 2025
+8.3%
Mar 2025
+7.4%
Dec 2024
+3.4%
Sep 2024
+6.1%
At each fiscal year end
Single quarter
Free cash flow, TTM
-$6.1M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM GHM
FY Mar 2026
-$121.0K
FY Mar 2025
$5.4M
FY Mar 2024
$18.9M
FY Mar 2023
$10.2M
FY Mar 2022
-$4.5M
Jun 2026
-$15.3M
Mar 2026
-$2.7M
Dec 2025
$2.4M
Sep 2025
$9.4M
Jun 2025
-$9.3M
Mar 2025
-$8.7M
Dec 2024
-$2.1M
Sep 2024
$10.4M
At each fiscal year end
Single quarter
Debt to equity
0.00x
long-term 2026-06-30 plus current 2024-03-31 (27 months older than the period end); equity 2026-06-30
Debt to equity GHM
FY Mar 2026
0.09x
FY Mar 2025
0.00x
FY Mar 2024
0.00x
FY Mar 2023
0.12x
FY Mar 2022
0.19x
Jun 2026
0.00x
Mar 2026
0.09x
Dec 2025
0.00x
Sep 2025
0.00x
Jun 2025
0.00x
Mar 2025
0.00x
Dec 2024
0.00x
Sep 2024
0.00x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt to cover
Cash flow to debt GHM
FY Mar 2026
1.23x
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
1.18x
FY Mar 2022
-0.12x
Jun 2026
n/a
Mar 2026
1.23x
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+7.5%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity GHM
FY Mar 2026
+9.6%
FY Mar 2025
+10.9%
FY Mar 2024
+4.5%
FY Mar 2023
+0.4%
FY Mar 2022
-9.0%
Jun 2026
+7.5%
Mar 2026
+9.6%
Dec 2025
+12.1%
Sep 2025
+11.4%
Jun 2025
+12.0%
Mar 2025
+10.9%
Dec 2024
+8.4%
Sep 2024
+7.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+3.8%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets GHM
FY Mar 2026
+4.3%
FY Mar 2025
+4.9%
FY Mar 2024
+2.1%
FY Mar 2023
+0.2%
FY Mar 2022
-5.3%
Jun 2026
+3.8%
Mar 2026
+4.3%
Dec 2025
+5.4%
Sep 2025
+5.1%
Jun 2025
+5.6%
Mar 2025
+4.9%
Dec 2024
+3.8%
Sep 2024
+3.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+8.7%
operating income after a 15.2% effective tax rate, over long-term 2026-06-30 plus current 2024-03-31 (27 months older than the period end) plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital GHM
FY Mar 2026
+9.9%
FY Mar 2025
+12.9%
FY Mar 2024
+6.8%
FY Mar 2023
+0.9%
FY Mar 2022
n/a
Jun 2026
+8.7%
Mar 2026
+9.9%
Dec 2025
+15.3%
Sep 2025
+14.5%
Jun 2025
+13.8%
Mar 2025
+12.9%
Dec 2024
+10.5%
Sep 2024
+10.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+8.5%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed GHM
FY Mar 2026
+10.2%
FY Mar 2025
+12.5%
FY Mar 2024
+5.9%
FY Mar 2023
+1.0%
FY Mar 2022
-10.1%
Jun 2026
+8.5%
Mar 2026
+10.2%
Dec 2025
+13.7%
Sep 2025
+13.2%
Jun 2025
+13.6%
Mar 2025
+12.5%
Dec 2024
+9.4%
Sep 2024
+8.2%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
66.28x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing GHM
FY Mar 2026
70.46x
FY Mar 2025
25.96x
FY Mar 2024
63.44x
FY Mar 2023
654.00x
FY Mar 2022
n/a
Jun 2026
120.18x
Mar 2026
70.46x
Dec 2025
47.58x
Sep 2025
44.27x
Jun 2025
39.29x
Mar 2025
25.96x
Dec 2024
53.58x
Sep 2024
41.68x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$774.3M
market value at close 2026-10-26 on 2026-08-04 shares, plus long-term 2026-06-30 plus current 2024-03-31 (27 months older than the period end), minus cash 2026-06-30
Enterprise value GHM
FY Mar 2026
$880.3M
FY Mar 2025
$292.6M
FY Mar 2024
$278.5M
FY Mar 2023
$132.6M
FY Mar 2022
$85.7M
Jun 2026
$1.4B
Mar 2026
$880.3M
Dec 2025
$683.5M
Sep 2025
$582.0M
Jun 2025
$531.3M
Mar 2025
$292.6M
Dec 2024
$454.2M
Sep 2024
$290.0M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-0.8%
TTM free cash flow over market value at close 2026-10-26
FCF yield GHM
FY Mar 2026
-0.0%
FY Mar 2025
+1.7%
FY Mar 2024
+6.4%
FY Mar 2023
+7.3%
FY Mar 2022
-5.5%
Jun 2026
-0.4%
Mar 2026
-0.0%
Dec 2025
-0.9%
Sep 2025
-1.8%
Jun 2025
-1.8%
Mar 2025
+1.7%
Dec 2024
+3.9%
Sep 2024
+8.2%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -18%, PEG needs growth
PEG, trailing GHM
FY Mar 2026
78.22x
FY Mar 2025
0.16x
FY Mar 2024
0.03x
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
n/a
Mar 2026
78.22x
Dec 2025
0.76x
Sep 2025
0.59x
Jun 2025
0.22x
Mar 2025
0.16x
Dec 2024
0.24x
Sep 2024
0.26x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
GHM ranks highest on financial health (99th percentile) and growth (69th), and lowest on institutional and government (20th), among Industrials peers.
Profitability
47
Inputs
Return on equity+7.5% · 45 pct, sector of 198
Return on assets+3.8% · 51 pct, sector of 224
Return on invested capital+8.7% · 37 pct, sector of 107
Return on capital employed+8.5% · 54 pct, sector of 195
Financial health
100
Inputs
Debt to equity0.00x · 100 pct, sector of 215
Cash flow to debtno debt to cover
Growth
69
Inputs
Revenue growth, YoY+16.9% · 79 pct, sector of 255
Backlog growth, YoY+15.4% · 58 pct, sector of 90
Institutional and government
20
Inputs
Funds adding, latest quarterfewer than five funds report holding it
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quarters$120K · 20 pct, sector of 67
Risk and compliance
63
Inputs
Short interest, % of float+8.8% · 20 pct, sector of 271
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 192
New text in Risk Factors, latest 10-K+7.8% · 69 pct, sector of 197
2 not measured: Insider conviction, US patents
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
GHM filings, in plain words
Are there planned insider sales of GHM?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $5.6M of stock; the latest, by Thoren Daniel J., was filed 2026-08-13.
Read the full summary
Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $5.6M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.